Femasys Inc.

Contributing Author

Recent Articles by Femasys Inc.

Jul-01	Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed for First-Line Infertility Treatment and FemVue Diagnostic FEMY GlobeNewswire
Jun-25	Femasys Announces Historic Milestone with European Approval of FemBloc, the First Non-Surgical Permanent Birth Control FEMY GlobeNewswire
Jun-17	Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth FEMY GlobeNewswire
Jun-11	Femasys Announces Partnership with Carolinas Fertility Institute, One of America's Best Fertility Clinics, to Offer FemaSeed in its More than 8 Locations FEMY GlobeNewswire
May-30	Femasys Announces Pricing of Underwritten Public Offering and Concurrent Private Placement with Gross Proceeds of $4.5 Million FEMY GlobeNewswire
May-29	Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement FEMY GlobeNewswire
May-08	Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update FEMY GlobeNewswire